Funding · Company

Cambrian BioPharma Inc

New York, NYBiotech & Pharma

Cambrian BioPharma Inc of New York, NY has disclosed $115M across 2 Form D offerings filed with the SEC between Dec 2, 2021 and Jan 13, 2025.

$115M

Total disclosed

Form D offerings

2019

Incorporated

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$23M

Form D · Jan 13, 2025 ↗

Q1 2025 · 1 amendment, first filed Dec 22, 2023 · target $38M

$92M

Form D · Dec 2, 2021 ↗

Q4 2021 · target $101M

Filing details

HeadquartersNew York, NYIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2019SEC CIK0001797409Offerings on file2

Links

All SEC filings for this company ↗ cambrianbiopharma.com ↗ Startups in New York → More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →